Hirose, Asao
Koh, Hideo
Nakamae, Mika http://orcid.org/0000-0002-9200-4804
Nakashima, Yasuhiro http://orcid.org/0000-0003-3025-723X
Nishimoto, Mitsutaka http://orcid.org/0000-0002-0388-3836
Okamura, Hiroshi
Makuuchi, Yosuke http://orcid.org/0000-0002-5230-6904
Kuno, Masatomo http://orcid.org/0000-0003-4548-147X
Takakuwa, Teruhito
Ido, Kentaro
Sakatoku, Kazuki
Hino, Masayuki
Nakamae, Hirohisa http://orcid.org/0000-0003-4203-990X
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (23K06746)
the Project Mirai Cancer Research Grants
Article History
Received: 27 November 2023
Revised: 24 January 2024
Accepted: 25 January 2024
First Online: 14 February 2024
Competing interests
: The potential conflicts of interest for each author are as follows: HK received honoraria from Novartis. MNa’s spouse received honoraria (HN’s interests). YN received research funding from Astellas, Chugai, Novartis, and honoraria from Astellas, Kyowa Kirin, and Chugai. MNi received research funding from Astellas and Pfizer, and honoraria from Nippon Shinyaku, Otsuka, and Takeda. HO received research funding from Takeda, and honoraria from Nippon Shinyaku. TT received research funding from Pfizer, and honoraria from Chugai, Kyowa Kirin, Novartis, Takeda, and Sanofi. MH received research funding from Nippon Shinyaku; scholarship grants from Chugai, JCR Pharmaceuticals, Kyowa Kirin, Takeda, and Otsuka; and honoraria from Astellas, Chugai, Kyowa Kirin, Nippon Shinyaku, Novartis, Otsuka, Pfizer, Sanofi, and Takeda. HN received research funding from Astellas, Novartis, and Takeda, and honoraria from Astellas, Chugai, Nippon Shinyaku, Novartis, Otsuka, and Takeda. This study was not funded by any of these companies. The other authors declare no conflicts of interest associated with this manuscript.